SCHEMBL30320367

SCHEMBL30320367

Cn1ccc(OC(=O)c2ccccc2)n1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 11/20 0.54
MAPT P10636 8/20 0.54
TSHR P16473 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.47
HPGD P15428 2/20 0.47
KDM4E B2RXH2 1/20 0.47
ALDH1A1 P00352 2/20 0.46
LMNA P02545 3/20 0.45
MEN1 O00255 1/20 0.45
PKM P14618 1/20 0.44
JMJD6 Q6NYC1 3/20 0.44
GRM5 P41594 1/20 0.43
F2 P00734 1/20 0.42
ALOX15 P16050 1/20 0.42
USP2 O75604 1/20 0.41
HSD17B10 Q99714 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31629807 0.83 ALDH1A1 (0.54) KMT2AMAPTTSHRKDM4EALDH1A1
SCHEMBL27600721 0.80 KMT2A (0.50) KMT2AMAPTTSHRSMN1; SMN2HPGD
SCHEMBL27690103 0.79 KMT2A (0.60) KMT2AMAPTTSHRSMN1; SMN2HPGD
SCHEMBL25117691 0.69 KMT2A (0.35) KMT2ATSHRSMN1; SMN2KDM4EALDH1A1
SCHEMBL2804720 0.69 KMT2A (0.52) KMT2AMAPTTSHRSMN1; SMN2KDM4E
Phosphine SCHEMBL9591710 0.69 LMNA (0.67) KMT2AMAPTTSHRSMN1; SMN2ALDH1A1
SCHEMBL30532884 0.68 LMNA (0.53) KMT2AMAPTTSHRSMN1; SMN2HPGD
SCHEMBL2829058 0.68 LMNA (0.53) KMT2AMAPTTSHRSMN1; SMN2HPGD
SCHEMBL28690697 0.68 TSHR (0.50) KMT2AMAPTTSHRSMN1; SMN2HPGD
SCHEMBL31396932 0.68 LMNA (0.49) KMT2AMAPTTSHRSMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4161494-A1 NITROGEN-CONTAINING FUSED BICYCLIC COMPOUNDS AND THEIR USE AS UBIQUITIN-SPECIFIC-PROCESSING PROTEASE 1 (USP1) INHIBITORS KSQ Therapeutics, Inc. (US) 2023-04-12 EP disclosed